Veterinary Medicine Information website

Marfloxin 5 mg Tablets for Cats and Dogs

Authorised
  • Marbofloxacin

Product identification

Medicine name:
Marfloxin 5 mg Tablets for Cats and Dogs
Active substance:
  • Marbofloxacin
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Marbofloxacin
    5.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • box containing 100 tablets (10 blister)
  • box containing 10 tablets (1 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • TAD Pharma GmbH
  • Krka-Farma d.o.o.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/12/0073
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0317/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 20/02/2026

Summary of Product Characteristics

English (PDF)
Published on: 14/03/2026
Download

eu-PUAR-esv0317001-dcp-marfloxin-5-mg-tablets-for-cats-and-dogs-en.pdf

English (PDF)
Published on: 21/12/2023
Download